• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

New Water Acquires Trillium Health Care Products

Share:

August 27, 2018

An affiliate of New Water Capital L.P., a Boca Raton-based private equity firm focused on lower-middle market companies, announced today its acquisition of Trillium Health Care Products, a premier contract manufacturer of category-leading OTC products for some of the world’s top pharmaceutical companies.

Based in Brockville, Ontario, Trillium has built a reputation in the pharmaceutical industry for its focus on quality and technical expertise in short and medium production runs across three dosage forms: liquid, solid and semi-solid. The existing Trillium executive team will continue to manage the company, with General Manager Jay Webb taking on the role of President.

“Trillium’s long-standing customer relationships and status as ‘partner of choice’ to many iconic consumer brands speaks to its impeccable quality control, stellar on-time record and excellent service,” said New Water Capital partner Jason Neimark. “We look forward to working with Jay and the Trillium team to identify opportunities to expand our capacity and support our customers in this rapidly growing sector.”

“New Water has demonstrated success with two contract manufacturing companies that have prospered under its management and operations support,” Webb said. “Our partnership with New Water will allow Trillium to invest in our facilities, capabilities and personnel to continue to service our blue-chip customer base. We think it’s a great fit.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Lincoln International served as Trillium’s exclusive representative in the sale. New Water Capital was represented by Stikeman Elliot and Kirkland & Ellis.

Trillium is the tenth company added to the New Water portfolio since the fund closed in June 2015, and the third quality-focused and regulated contract manufacturer, joining Pegasus Foods, a leading contract manufacturer of frozen appetizers and snacks, and Custom Made Meals, a leading manufacturer of fresh, oven-ready, value-added entrees and appetizers.

Date: August 27, 2018

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Podimetrics Secures $45M for SmartMat to Prevent Diabetic Amputations in High-Risk PatientsPodimetrics Secures $45M for SmartMat to Prevent Diabetic Amputations in High-Risk Patients
  • Sumitovant Biopharma and Urovant Sciences Announce Sumitovant’s Acquisition of Remaining Stake in UrovantSumitovant Biopharma and Urovant Sciences Announce Sumitovant’s Acquisition of Remaining Stake in Urovant
  • GoodRx Acquires Telemedicine Company HeyDoctor To Add Virtual Healthcare ServicesGoodRx Acquires Telemedicine Company HeyDoctor To Add Virtual Healthcare Services
  • The Global Pharmaceutical Manufacturing Market Will Grow to $509.45 Billion By 2026, at a CAGR of 12.38% – ResearchAndMarkets.comThe Global Pharmaceutical Manufacturing Market Will Grow to $509.45 Billion By 2026, at a CAGR of 12.38% – ResearchAndMarkets.com
  • Life Science Cares Announces Impact Level Partnership with Kura OncologyLife Science Cares Announces Impact Level Partnership with Kura Oncology
  • 5 Reasons Why Providers Need Electronic Support for Glycemic Management5 Reasons Why Providers Need Electronic Support for Glycemic Management
  • North Carolina Taps Phreesia to Help with Social Determinants of HealthNorth Carolina Taps Phreesia to Help with Social Determinants of Health
  • Rafael Pharmaceuticals Launches Clinical Trial Web Portal “Rafael Trial Connect”Rafael Pharmaceuticals Launches Clinical Trial Web Portal “Rafael Trial Connect”

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications